arrow
S

Scott Wiseman

University of Leeds
H指数:15
被引数:637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of Credelio Quattro™ chewable tablets containing lotilaner, moxidectin, pyrantel, and praziquantel against Ctenocephalides felis and Rhipicephalus sanguineus infestations on dogs

含有卢他兰、摩西克丁、吡喹酮和吡喹酮的Credelio Quattro™咀嚼片对犬体上猫栉首蚤和血红扇头蜱感染的疗效

2026-04-270
OAAI
Efficacy of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) chewable tablets in the prevention of Borrelia burgdorferi transmission from infected Ixodes scapularis in dogs

Credelio Quattro™(lotilaner、moxidectin、praziquantel和pyrantel咀嚼片)和Credelio™(lotilaner)咀嚼片在预防受感染Ixodes scapularis传播Borrelia burgdorferi至犬中的效果

2025-12-060
OAAI
Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs

一种新型咀嚼片的功效 (Credelio Quattro™) 含有lotilaner,moxidectin,吡喹酮和pyrantel,用于治疗和控制狗的钩虫感染

2025-04-020
OAAI
Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) for the prevention of heartworm disease (Dirofilaria immitis) in client-owned dogs in the USA

一项现场研究,旨在评估含米尔贝霉素氧肟和洛替拉尼的新口服复方制剂(Credelio)的有效性和安全性。®此外)用于美国境内客户所有犬只的心丝虫病(犬心丝虫)的预防

2021-05-284
OAAI
Effectiveness of Credelio® Plus, a novel chewable tablet containing milbemycin oxime and lotilaner for the treatment of larval and immature adult stages of Toxocara canis in experimentally infected dogs

Credelio的有效性®另外,一种新型的咀嚼片含有米尔贝霉素肟和lotilaner,用于治疗实验感染的犬弓形虫的幼虫和未成熟成年阶段

2021-05-174
OAAI